Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

1.

Therapeutic potential of ixmyelocel-t, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases.

Ledford KJ, Murphy N, Zeigler F, Bartel RL, Tubo R.

Stem Cell Res Ther. 2015 Mar 13;6(1):25. [Epub ahead of print]

PMID:
25889271
2.

Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathy.

Henry TD, Traverse JH, Hammon BL, East CA, Bruckner B, Remmers AE, Recker D, Bull DA, Patel AN.

Circ Res. 2014 Sep 26;115(8):730-7. doi: 10.1161/CIRCRESAHA.115.304554. Epub 2014 Aug 20.

PMID:
25142002
3.

Determination of the fate and contribution of ex vivo expanded human bone marrow stem and progenitor cells for bone formation by 2.3ColGFP.

Yin D, Wang Z, Gao Q, Sundaresan R, Parrish C, Yang Q, Krebsbach PH, Lichtler AC, Rowe DW, Hock J, Liu P.

Mol Ther. 2009 Nov;17(11):1967-78. doi: 10.1038/mt.2009.151. Epub 2009 Jul 14.

4.

Identification of essential genes in Staphylococcus aureus by construction and screening of conditional mutant library.

Yin D, Ji Y.

Methods Mol Biol. 2008;416:297-305. doi: 10.1007/978-1-59745-321-9_19.

PMID:
18392975
5.
7.
8.
9.
10.

Tissue culture surface characteristics influence the expansion of human bone marrow cells.

Koller MR, Palsson MA, Manchel I, Maher RJ, Palsson BO.

Biomaterials. 1998 Nov;19(21):1963-72.

PMID:
9863530
11.

Alternatives to animal sera for human bone marrow cell expansion: human serum and serum-free media.

Koller MR, Maher RJ, Manchel I, Oxender M, Smith AK.

J Hematother. 1998 Oct;7(5):413-23.

PMID:
9829315
12.

Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging.

Lundell BI, Vredenburgh JJ, Tyer C, DeSombre K, Smith AK.

Bone Marrow Transplant. 1998 Jul;22(2):153-9.

14.

Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system.

Koller MR, Manchel I, Maher RJ, Goltry KL, Armstrong RD, Smith AK.

Bone Marrow Transplant. 1998 Apr;21(7):653-63.

15.
16.
17.

flt-3 ligand is more potent than c-kit ligand for the synergistic stimulation of ex vivo hematopoietic cell expansion.

Koller MR, Oxender M, Brott DA, Palsson BO.

J Hematother. 1996 Oct;5(5):449-59.

PMID:
8938517
18.

Different measures of human hematopoietic cell culture performance are optimized under vastly different conditions.

Koller MR, Manchel I, Palsson MA, Maher RJ, Palsson BØ.

Biotechnol Bioeng. 1996 Jun 5;50(5):505-13.

PMID:
18627012
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk